Opaleye Management as of June 30, 2014
Portfolio Holdings for Opaleye Management
Opaleye Management holds 27 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chimerix (CMRX) | 14.9 | $17M | 790k | 21.94 | |
| Retrophin | 12.3 | $14M | 1.2M | 11.74 | |
| Ariad Pharmaceuticals | 9.1 | $11M | 1.7M | 6.37 | |
| Pharmacyclics | 7.7 | $9.0M | 100k | 89.71 | |
| GenMark Diagnostics | 5.8 | $6.8M | 500k | 13.53 | |
| Bind Therapeutics | 5.6 | $6.5M | 492k | 13.18 | |
| Inspiremd Com New | 5.5 | $6.4M | 2.2M | 2.95 | |
| Cempra | 4.7 | $5.4M | 505k | 10.73 | |
| Clovis Oncology | 4.6 | $5.4M | 130k | 41.30 | |
| Agios Pharmaceuticals (AGIO) | 4.5 | $5.3M | 115k | 45.82 | |
| Cardiovascular Systems | 3.6 | $4.2M | 135k | 31.16 | |
| Catalyst Pharmaceutical Partners (CPRX) | 3.0 | $3.5M | 1.4M | 2.53 | |
| Insys Therapeutics Com New | 2.3 | $2.7M | 86k | 31.24 | |
| Tetraphase Pharmaceuticals | 2.0 | $2.3M | 170k | 13.49 | |
| Mazor Robotics Ltd. equities | 1.8 | $2.1M | 120k | 17.57 | |
| Ultragenyx Pharmaceutical (RARE) | 1.7 | $2.0M | 45k | 44.89 | |
| Evoke Pharma | 1.7 | $2.0M | 243k | 8.09 | |
| Recro Pharma | 1.5 | $1.8M | 220k | 8.01 | |
| Celgene Corp Right 12/31/2030 | 1.5 | $1.7M | 660k | 2.60 | |
| Karyopharm Therapeutics | 1.2 | $1.4M | 30k | 46.57 | |
| Biolinerx Ltd-spons | 1.2 | $1.4M | 650k | 2.08 | |
| Codexis (CDXS) | 1.0 | $1.2M | 820k | 1.46 | |
| Celator Pharmaceuticals | 0.9 | $1.1M | 338k | 3.17 | |
| Kalobios Pharmaceuticals | 0.6 | $730k | 320k | 2.28 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $455k | 7.2k | 63.19 | |
| Kips Bay Med | 0.3 | $355k | 772k | 0.46 | |
| Prothena (PRTA) | 0.3 | $295k | 13k | 22.51 |
